IMMUNOHISTOCHEMISTRY, NEURON SPECIFIC ENOLASE (NSE)

The IHC – Neuron Specific Enolase (NSE) test is an immunohistochemistry-based diagnostic assay used to detect NSE protein expression in tissue samples. NSE is an enzyme commonly found in neuronal cells and neuroendocrine tissues, making it an important marker for identifying tumors of neural and neuroendocrine origin.

This test is widely used in pathology to help diagnose neuroendocrine tumors, small cell carcinomas, and certain tumors arising from nerve tissue. NSE staining assists pathologists in determining tumor origin and differentiating neuroendocrine malignancies from other cancer types.

Benefits of the Test

• Helps diagnose neuroendocrine tumors
• Assists in identifying neural-origin cancers
• Supports classification of small cell carcinomas
• Improves tumor differentiation accuracy
• Aids oncologists in treatment planning and prognosis evaluation

Why Doctors Recommend This Test

Doctors recommend the IHC NSE test when there is suspicion of neuroendocrine or neural tissue tumors. It is commonly used in:

• Evaluation of neuroendocrine tumors
• Diagnosis of small cell lung carcinoma
• Investigation of neural and nerve tissue tumors
• Differentiation of poorly differentiated malignancies
• Oncology biopsy interpretation

NSE is often used alongside other neuroendocrine markers such as chromogranin, synaptophysin, CD56, and Ki-67 to improve diagnostic accuracy.

Preparation Before Test

No special preparation is required for this test. Important points include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting or medication restrictions are necessary
• Clinical history and imaging findings may support interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on sample processing and laboratory workflow.

Who Should Take This Test

• Patients with suspected neuroendocrine tumors
• Individuals with small cell carcinoma suspicion
• Cases requiring neural-origin tumor confirmation
• Patients undergoing oncology biopsy evaluation
• Individuals with poorly differentiated tumors needing classification

The IHC NSE test is an important diagnostic tool in modern oncopathology and neuropathology. By identifying neuronal and neuroendocrine differentiation in tissue samples, it helps clinicians establish accurate diagnoses and develop effective treatment plans.